NCT00113945View on ClinicalTrials.gov

Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)

PHASE2CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

July 31, 2003

Conditions
End Stage Renal Disease
Interventions
DRUG

Cinacalcet

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00113945 - Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD) | Biotech Hunter | Biotech Hunter